Executive Director, Rebate Finance Strategy

CVS Health•Cumberland, RI

20h•$131,500 - $303,195

About The Position

CVS Health's Pharmacy Services Finance Team is seeking an Executive Director to lead the Rebate Financial Strategy & Drug Profitability function. The role serves as strategic finance leader for CVS Health's $70B+ annual rebate portfolio, providing financial stewardship, analytical rigor, and executive-level insight to influence pricing strategy, margin optimization, and long-term profitability across the PBM business. The Executive Director sets the strategic direction, governance model, and executive decision framework for rebate financial performance and drug-level profitability across the enterprise. The position partners closely with VP and CFO leadership, Trade Strategy, Underwriting, and cross-functional stakeholders to shape rebate strategy, govern enterprise-wide drug-level financial assumptions, and translate pricing, utilization, contract, and regulatory dynamics into actionable executive decision-making narratives. It requires command of PBM economics, financial modeling, strategic storytelling, transformation leadership, and cross-functional influence.

Requirements

12+ years of progressive finance leadership experience, preferably in healthcare, PBM, managed care, or similarly complex industries.
Demonstrated experience managing P&L and presenting to SVP and C-suite leadership, with the ability to influence executive decisions through financial insights and strategic recommendations.
Deep fluency in PBM economics, including rebate structures, network and channel pricing, pharma contracting, dispensing economics, and drug-level profitability drivers.
Expertise in budgeting, forecasting, and multi-year financial modeling within a large, matrixed organization, including scenario analysis and sensitivity modeling.
Ability to translate complex financial, regulatory, and competitive data into clear executive communications and decision-ready narratives.
Track record of building and leading high-performing finance teams, with success in talent development and organizational scaling.
Advanced financial modeling, analytical, problem-solving, and executive presentation skills, with strong proficiency in Excel and enterprise reporting tools.
Experience establishing governance frameworks and standardizing processes across cross-functional stakeholders in a matrixed organization.
Executive presence and ability to influence senior leaders, challenge assumptions, and drive alignment across complex business issues.
Bachelor's degree in Finance, Accounting, Economics, Business Administration, or a related field.

Nice To Haves

Familiarity with the state and federal PBM regulatory environment, including FTC, CMS, and state-level pharmacy benefit legislation.
Experience with enterprise planning platforms such as SAP, Anaplan, or equivalent tools, and success in forecasting transformation.
Experience leveraging AI and machine learning tools to enhance finance productivity and insight generation.
Proficiency with Tableau, SQL, SAP, and BI tools to support finance analytics, reporting, and transformation initiatives.
Background in competitive intelligence and external benchmarking within the PBM or healthcare payer space.
Experience with GLP-1 drugs, biosimilars, generic launches, and other high-impact drug categories.
Knowledge of Trade Capacity modeling, MYR processes, and COGS improvement initiatives.
Experience with assumptions governance, SSOT development, and cross-functional alignment on financial methodologies.
MBA or advanced degree, preferably concentrated in Finance, Strategy, or Healthcare Administration.

Responsibilities

Lead financial strategy, planning, and performance management for the $70B+ rebate portfolio.
Partner with senior Finance and business leaders to drive margin optimization and long-term profitability.
Deliver executive insights on financial performance, emerging risks, market dynamics, and regulatory impacts.
Evaluate drug and market trends to inform strategic planning and forecast accuracy.
Establish and govern enterprise-wide financial assumptions and forecasting methodologies.
Maintain a centralized assumptions framework that supports consistency, transparency, and decision-making.
Align cross-functional stakeholders on critical drivers affecting pricing, profitability, and growth.
Strengthen governance and controls to improve forecast accuracy and financial performance.
Lead enterprise drug profitability analytics and reporting strategy.
Develop actionable insights into profitability drivers, market dynamics, and financial performance.
Deliver scenario modeling and executive decision support for strategic initiatives and investments.
Lead development of the Trade Capacity Model, a key driver of long-term profitability and COGS improvement.
Direct financial modeling and planning inputs supporting enterprise budget and multi-year forecasting processes.
Lead finance transformation initiatives that enhance forecasting, reporting, and operational effectiveness.
Advance analytics, automation, AI, and technology solutions to improve decision-making and productivity.
Oversee investment governance and portfolio prioritization to maximize business value and financial returns.
Drive organizational change management and adoption of new operating models and technologies.
Build, lead, and develop a high-performing team focused on strategic finance, analytics, and business performance.
Foster a culture of accountability, innovation, and continuous improvement.
Partner across Finance, Trade, Underwriting, and Operations to align strategy and business objectives.
Serve as a trusted advisor to senior leadership on profitability, growth, and enterprise financial strategy.